SCHEMBL186172

SCHEMBL186172

O=C(O)CN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEP1B Q16820 3/20 0.50
AKR1B1 P15121 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CA12 O43570 1/20 0.48
CA9 Q16790 1/20 0.48
HDAC3 O15379 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
NCOR2 Q9Y618 2/20 0.47
LMNA P02545 2/20 0.47
KEAP1 Q14145 1/20 0.46
NPSR1 Q6W5P4 2/20 0.46
ALDH1A1 P00352 1/20 0.46
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27504556 0.98 MEP1B (0.49) MEP1BAKR1B1MEN1KMT2ATDP1
SCHEMBL212272 0.98 AKR1B1 (0.52) MEP1BAKR1B1MEN1KMT2ATDP1
SCHEMBL2799777 0.91 TDP1 (0.52) MEP1BAKR1B1MEN1KMT2ATDP1
SCHEMBL11586184 0.91 MEP1B (0.47) MEP1BAKR1B1MEN1KMT2ATDP1
SCHEMBL17083315 0.90 MEP1B (0.56) MEP1BLMNAALDH1A1PPARGPPARA
SCHEMBL12243695 0.90 TDP1 (0.56) MEP1BAKR1B1MEN1KMT2ATDP1
SCHEMBL2807141 0.90 TDP1 (0.56) AKR1B1MEN1KMT2ATDP1NPC1
SCHEMBL2284795 0.90 TDP1 (0.56) MEP1BAKR1B1MEN1KMT2ATDP1
SCHEMBL17083312 0.89 MEP1B (0.55) MEP1BMEN1KMT2ATDP1NPC1
SCHEMBL7564337 0.88 TDP1 (0.58) AKR1B1TDP1NPC1RAB9ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115073312-B Synthesis method of norepinephrine bitartrate 上海现代哈森(商丘)药业有限公司 2023-10-03 CN claimed
CN-115073312-A Novel synthesis method of noradrenaline bitartrate 上海现代哈森(商丘)药业有限公司 2022-09-20 CN claimed
CN-1332944-C Amino acid accelerated CuI catalyzed aryl halide and coupling reaction of alkyl sulfonate SHANGHAI INST ORGANIC CHEM (CN) 2007-08-22 CN claimed
CN-1288117-C Coupling reaction of end group alkine and aryl halide SHANGHAI INST ORGANIC CHEM (CN) 2006-12-06 CN claimed
CN-1651408-A Amino acid accelerated CuI catalyzed aryl halide and coupling reaction of alkyl sulfonate SHANGHAI INST ORGANIC CHEM (CN) 2005-08-10 CN claimed
WO-2025088200-A2 ACID PHOSPHATASE 3 LIGANDS FOR TARGETED DELIVERY APPLICATIONS PHILOCHEM AG (CH) 2025-05-01 WO disclosed
CN-113402666-B Dental photocurable composition excellent in color tone selectivity 株式会社松风 2024-11-15 CN disclosed
US-12064493-B2 Dental photocurable composition having excellent storage stability SHOFU INC. (JP) 2024-08-20 US disclosed
US-12011490-B2 Dental photocurable composition excellent in operability and storage stability SHOFU INC. (JP) 2024-06-18 US disclosed
EP-3888616-B1 DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN COLOR TONE SELECTIVITY SHOFU INC (JP) 2024-05-15 EP disclosed
CN-116675613-B Method for preparing norepinephrine bitartrate by chiral resolution 北京元延医药科技股份有限公司 2023-10-10 CN disclosed
CN-116675612-B Method for dynamic kinetic resolution of racemic norepinephrine 北京元延医药科技股份有限公司 2023-10-10 CN disclosed
US-4945106-A Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1990-07-31 US disclosed
US-4596823-A Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-06-24 US disclosed
EP-0043292-B1 PROSTAGLANDINS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-01-15 EP disclosed
EP-0078766-B1 PROCESS FOR PREPARING AMINOMETHYLPHOSPHONIC ACID CIBA-GEIGY AG (CH) 1985-04-17 EP disclosed
EP-0111955-A1 Prostaglandin intermediates NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1984-06-27 EP disclosed
US-4368162-A Process for producing aminomethylphosphonic acid CIBA-GEIGY CORPORATION (US) 1983-01-11 US disclosed
WO-1982000142-A1 PROSTAGLANDINS JONES R 1982-01-21 WO disclosed
EP-0043292-A2 Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1982-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12064493-B2 Dental photocurable composition having excellent storage stability H1-0, H1-2, H1-4 MEP1B 938/4885AKR1B1 3493/4885MEN1 1650/4885
US-12011490-B2 Dental photocurable composition excellent in operability and storage stability H1-0, CCND1, CCNT1 MEP1B 360/4885AKR1B1 2327/4885MEN1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.